Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2003
05/01/2003US20030083344 Tryptase inhibitors
05/01/2003US20030083343 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
05/01/2003US20030083335 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083315 Benzimidazole derivatives for treating an inflammatory disease, an allergy disease, a respiratory disease, a cardiovascular disorder or a bone disorder
05/01/2003US20030083286 Comprises penetration enhancer (fatty acid); drug delivery; increases bioavailability of oligonucleotides
05/01/2003US20030083272 Sense mrna therapy
05/01/2003US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease
05/01/2003US20030083265 TGF-beta inhibitors and methods
05/01/2003US20030083262 Methods and compositions for treating inflammatory disorders
05/01/2003US20030083256 Compositions and methods for enhancing drug delivery across and into epithelial tissues
05/01/2003US20030083254 Heparanase-like proteins and nucleotides that encode them
05/01/2003US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule
05/01/2003US20030083242 Methods and compositions for treating or preventing peripheral neuropathies
05/01/2003US20030082784 Novel peptide having osteogenetic activity and osteogenetic accelerator containing the same
05/01/2003US20030082748 Nucleotide sequences coding polypeptides for use in the treatment of leukemia, tumors, psoriasis, chronic infections, autoimmune and fibrotic disorders; wound healing agents
05/01/2003US20030082672 Dna encoding galanin galr2 receptors and uses thereof
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082609 Nuceotide sequences coding polypeptide for use in humans therapeutics and diagnostics
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082245 Anti-inflammatory agent and foods and drinks containing the same
05/01/2003US20030082234 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
05/01/2003US20030082226 Non-steroidal antiinflammatory drug formulations for topical application to the skin
05/01/2003US20030082214 Oil in water emulsion containing antidepressant, anesthetics
05/01/2003US20030082207 Method of using HIV protease inhibiting compounds
05/01/2003US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases
05/01/2003US20030082135 Pathway of RANTES-mediated chemokine synthesis in astrocytes and methods of use therefor
05/01/2003US20030082105 Selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions
05/01/2003US20030079311 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle
05/01/2003CA2764642A1 Taste masking spill-resistant formulation
05/01/2003CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464271A1 Integrin targeting compounds
05/01/2003CA2464111A1 Phosphonic acid compounds as inhibitors of serine proteases
05/01/2003CA2464085A1 A combination product comprising melagatran and dexamethasone
05/01/2003CA2463951A1 Solid pharmaceutical formulation for a piperazine urea derivative
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
05/01/2003CA2463043A1 Combination of liponic acid and glutamine in food and pharmaceutical products
05/01/2003CA2461085A1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
05/01/2003CA2460680A1 Substituted indazole compounds for the treatment of inflammation
04/2003
04/30/2003CN1414971A Depsipeptide and congeners thereof for use as immunosuppressants
04/30/2003CN1414965A Sulfonamides and derivatives thereof that modulate the activeity of endothelin
04/30/2003CN1414961A Substituted oximes and hydrazones as neurokinin antagonists
04/30/2003CN1414960A Substituted piperidines, medicaments containing these compounds, and methods for production thereof
04/30/2003CN1414952A Heterocyclic compounds having sulfonic acid
04/30/2003CN1414950A Substituted pyrrole Mannich bases to treating paint and allergic reactions
04/30/2003CN1414864A Adhesive particle DNA constructs and method of making and using the same
04/30/2003CN1413724A Brain active effect matter for prevention and curing encephalopathy and developing intelligence and its preparation method
04/30/2003CN1413702A 金乌骨通胶囊及其制备工艺 Ukrainian bone Capsule and its preparation process
04/30/2003CN1413700A Drug for treating rheumatism
04/30/2003CN1413671A Capsule for treating arthralgia aggravated by cold and preparation method
04/30/2003CN1413650A Medicine for treating rheumatalgia
04/30/2003CN1413649A Pill for treating rheumatic carditis
04/30/2003CN1413645A Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof
04/30/2003CN1413639A Chinese medicine composition for treating prolapse of lumbar intervertebral disc and sciatica
04/30/2003CN1413637A Chinese medicine composite for treating rheumatism, rheumatic arthritis
04/30/2003CN1413635A Quick-acting rheumatic arthritis adhesive plaster and its preparation technology
04/30/2003CN1413628A External used medicine for treating external wound and its production method and application
04/30/2003CN1413623A Liniment for pain
04/30/2003CN1413614A Yubi pill-for treatment of rheumatism and atrophic arthritis and its preparation method
04/30/2003CN1413604A Method for preparing medicine for treatment of arthralgia-syndrome pain disease
04/30/2003CN1413602A Chinese medicine prescription for treatment of appendicitis
04/30/2003CN1413589A Composition of paeoniflorin and albiflorin and its preparation method
04/30/2003CN1413583A Low dose diclofenac sodium lozenge and its preparation method
04/30/2003CN1107072C Programing cell death induced molecule II
04/30/2003CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists
04/30/2003CN1107058C Subsitituted isoxazoles for treatment of inflammation
04/30/2003CN1106847C Medicated wine for curing rheumatism and rheumatoid disease and its preparing method
04/29/2003USRE38103 Preferential, nontoxic oxidoreductase inhibitors such as 5-Methanesulfonamido-6-(2,4-difluorophenylthio)-1-indanone administered for prophylaxis of gastrointestinal disorders
04/29/2003US6555710 Aminobenzophenones as inhibitors of IL-1 β and TNF-α
04/29/2003US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery
04/29/2003US6555651 Ligand binding site of rage and uses thereof
04/29/2003US6555562 2-Carboxybenzoyl-(N'-3,5-dichloroisonicotinoyl)-L-4aminophenyl alanine, for example; inhibit the binding of alpha-4 integrins to their ligands, use to treat immune or inflammatory disorders
04/29/2003US6555543 Inhibiting the effects of platelet activating factor (PAF).
04/29/2003US6555542 Sulfonamide lactam inhibitors of FXa and method
04/29/2003US6555541 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
04/29/2003US6555537 Piperazine derivatives and their use as anti-inflammatory agents
04/29/2003US6555535 Tricyclic biphenyl sulfonamide matrix metalloproteinase inhibitors
04/29/2003US6555518 2',2'-difluoronucleosides for suppressing rejection of transplants in mammals; for treatment of autoimmune diseases
04/29/2003US6555352 Peptide for use in human therapeutics and diagnostic compositions
04/29/2003US6555105 Method of treatment with a RANTES antagonist polypeptide
04/29/2003CA2123160C Controlled release formulation
04/29/2003CA2103571C Method of treating pulmonary inflammation
04/26/2003CA2409084A1 Anti-inflammatory agent and foods and drinks containing the same
04/26/2003CA2395909A1 Anti-inflammatory agent and foods and drinks containing the same
04/24/2003WO2003034275A2 Chimeric glycosylphosphatidylinositol containing peptides
04/24/2003WO2003034067A1 Modulation of tor
04/24/2003WO2003033720A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
04/24/2003WO2003033696A1 Vegf antisense compound
04/24/2003WO2003033664A2 Bone anti-resorptive compounds
04/24/2003WO2003033653A2 Affinity enhancement agents
04/24/2003WO2003033528A1 Cyclic peptides as g-protein-coupled receptor antagonists
04/24/2003WO2003033527A2 Cyclosporine analogue mixtures and their use as immunomodulating agents
04/24/2003WO2003033524A2 Peptidyl ketones as inhibitors of dpiv
04/24/2003WO2003033518A1 Steroidal compounds for inhibiting steroid sulphatase
04/24/2003WO2003033507A1 Benzylmalonic acid derivatives and proteasome inhibitors contaiing the same
04/24/2003WO2003033506A1 Aminoborane acid derivative and proteasome inhibitory drug containing the same
04/24/2003WO2003033502A1 Bicyclic oxopyridine and oxopyrimidine derivatives
04/24/2003WO2003033501A1 Himbacine analogues as thrombin receptor antagonists
04/24/2003WO2003033496A1 Beta-carbolin derivatives as ptp-inhibitors